Zepto founders Aadit Palicha and Kaivalya Vohra are raising about Rs 1,500 crore through structured debt to boost Indian ownership ahead of...

Welcome to a new edition of ETtech Unwrapped – our weekend newsletter packed with the most important stories this week. Let’s take a look.

Sources told ET that online pharmacy startup PharmEasy could hit the bourses this year, two years after its previous attempt. The company w...

Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore los...

Honasa Consumer, Mamaearth's parent, addressed recent allegations, labelling them as "misinformation." This and more in today’s ETtech Top ...

Tata 1mg’s net loss plummeted to Rs 313 crore from Rs 1,255 crore in the previous financial year. Over 80% of the company’s operating reven...

BigBasket and 1mg–two of the biggest digital assets of Tata group–are choosing debt over equity for expansion in a critical year for them. ...

In a shot in the arm for epharmacies, the Madras High Court overturned a previous ruling by a single-judge bench restricting online platfor...

Tata Digital-owned 1mg has beaten rival PharmEasy to pole position in the country’s e-pharmacy market in terms of gross merchandise value. ...

Tata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same...

The online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4

Goldman Sachs is likely to convert some of its loan to online pharmacy PharmEasy into equity. Buoyed by binding commitments from existing i...

Byju’s woes seem to have no end. The company has suffered a series of setbacks over the last year, including ED raids and valuation markdow...

PharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...

Online pharmacy PharmEasy recorded a positive ebitda of around Rs 14 crore, which means it is operationally profitable, even as one of its ...

The layoffs were attributed to a variety of factors, including restructuring, macroeconomic headwinds, and the ongoing Russia-Ukraine confl...

In today's ETtech Morning Dispatch newsletter: Pharmeasy and Cred are the newest entrants of India's startup unicorn club, BPM firms see hi...